Fengxun Biotech completed nearly 60 million yuan in seed and angel round financing.

36Kr learned that recently, "Fengxun Biotech" announced the completion of its seed and angel rounds of financing. The investors include Hanyuan Asset (Shanghai Jiao Tong University Foundation), Legend Capital, Zhongke Chuangxing, Shengjing Investment, Hongfeng Investment, etc. The financing funds will be used to accelerate the evolution of the core technology platform, team building, and the clinical translation and development of the first candidate product in the fields of hematological tumors, autoimmune diseases, etc.